Upgrade to SI Premium - Free Trial

Recursion Pharmaceuticals (RXRX)

3.63 +0.19 (5.52%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 21, 2026 11:27 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 20, 2026 11:32 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 19, 2026 11:55 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Aug 17 Filed by: Khan Najat August 18, 2026 5:45 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Aug 17 Filed by: Taylor Ben R August 18, 2026 5:44 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Aug 17 Filed by: Hallett David August 18, 2026 5:44 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 18, 2026 5:15 PM - SEC Filing Recursion Pharmaceuticals (RXRX) PT Lowered to $5.30 at Morgan Stanley August 17, 2026 8:58 AM - StreetInsider Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 13, 2026 12:58 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 12, 2026 11:57 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 10, 2026 4:59 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 7, 2026 12:43 PM - SEC Filing Form SCHEDULE 13G RECURSION PHARMACEUTICAL Filed by: STATE STREET CORP August 7, 2026 10:49 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Aug 04 Filed by: Borgeson Blake August 6, 2026 5:09 PM - SEC Filing Recursion Pharmaceuticals, Inc. (RXRX) Misses Q2 EPS by 1c August 5, 2026 6:47 AM - StreetInsider Form 10-Q RECURSION PHARMACEUTICAL For: Jun 30 August 5, 2026 6:33 AM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: Aug 05 August 5, 2026 6:32 AM - SEC Filing Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program August 5, 2026 6:30 AM - StreetInsider Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake August 4, 2026 1:37 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher August 4, 2026 10:35 AM - SEC Filing Recursion to Participate in Upcoming Investor Conferences August 4, 2026 8:00 AM - Globe NewsWire Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules July 31, 2026 4:30 PM - StreetInsider Form SCHEDULE 13G RECURSION PHARMACEUTICAL Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC July 31, 2026 11:40 AM - SEC Filing Form SCHEDULE 13G RECURSION PHARMACEUTICAL Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 10:42 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 30, 2026 4:11 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 29, 2026 4:10 PM - SEC Filing Form SCHEDULE 13G/A RECURSION PHARMACEUTICAL Filed by: BlackRock, Inc. July 29, 2026 3:22 PM - SEC Filing Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th July 29, 2026 8:30 AM - StreetInsider Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 27, 2026 4:16 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 21, 2026 4:12 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 20, 2026 4:11 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 17, 2026 4:11 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 16, 2026 4:13 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 15, 2026 4:13 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 14, 2026 4:08 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 13, 2026 4:32 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 10, 2026 4:10 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jul 07 Filed by: Borgeson Blake July 9, 2026 6:04 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 9, 2026 4:26 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 8, 2026 4:26 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 7, 2026 1:39 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake July 7, 2026 11:37 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 6, 2026 3:29 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jul 01 Filed by: Dar Zavain July 2, 2026 5:16 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jul 01 Filed by: Li Dean Y July 2, 2026 5:16 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 2, 2026 12:54 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher July 1, 2026 5:19 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Borgeson Blake June 22, 2026 4:33 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: HERSHBERG ROBERT June 22, 2026 4:33 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Michor Franziska June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Sun Elaine D June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Dar Zavain June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Li Dean Y June 22, 2026 4:32 PM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 17 Filed by: Bumpus Namandje June 22, 2026 4:32 PM - SEC Filing Form 8-K RECURSION PHARMACEUTICAL For: Jun 17 June 18, 2026 5:04 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher June 18, 2026 4:33 PM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Bumpus Namandje June 18, 2026 9:45 AM - SEC Filing Form 144 RECURSION PHARMACEUTICAL Filed by: Gibson Christopher June 18, 2026 9:37 AM - SEC Filing Form 4 RECURSION PHARMACEUTICAL For: Jun 15 Filed by: Taylor Ben R June 17, 2026 5:07 PM - SEC Filing The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It June 16, 2026 8:45 AM - PR NewsWire Full Article List